# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Jan 10, 2023

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2023-01-10
- Accepted by EDGAR: Jan 10, 2023, 06:05 ET
- Period: 2023-01-10
- Accession: 0001193125-23-005141
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000119312523005141/d416892d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000119312523005141/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000119312523005141/d416892d8k.htm

Filed Jan 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-005141. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.
